Nanoscale geometric electric field enhancement in organic photovoltaics

Generic design rules for electrode–organic semiconductor contacts that transcend specific materials are urgently required to guide the development of new electrodes and provide a framework for engineering this important class of interface. Herein a novel nanostructured window electrode is utilized in conjunction with three-dimensional electrostatic modeling to elucidate the importance of geometric electric field enhancement effects at the electrode interfaces in organic photovoltaics. The results of this study show that nanoscale protrusions at the electrode surfaces in organic photovoltaics dramatically improve the efficiency of photogenerated charge carrier extraction to the external circuit and that the origin of this improvement is the local amplification of the electrostatic field in the vicinity of said protrusions. This wholly geometric approach to engineering electrodes at the nanoscale is materials generic and can be employed to enhance the efficiency of charge carrier injection or extraction in a wide range of organic electronic devices

Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

Aims The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Non-ST-segment elevation myocardial infarction (NSTEMI) Registry aims to identify international patterns in NSTEMI management in clinical practice and outcomes against the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without ST-segment-elevation. Methods and results Consecutively hospitalised adult NSTEMI patients (n = 3620) were enrolled between 11 March 2019 and 6 March 2021, and individual patient data prospectively collected at 287 centres in 59 participating countries during a two-week enrolment period per centre. The registry collected data relating to baseline characteristics, major outcomes (inhospital death, acute heart failure, cardiogenic shock, bleeding, stroke/transient ischaemic attack, and 30-day mortality) and guideline-recommended NSTEMI care interventions: electrocardiogram pre- or in-hospital, prehospitalization receipt of aspirin, echocardiography, coronary angiography, referral to cardiac rehabilitation, smoking cessation advice, dietary advice, and prescription on discharge of aspirin, P2Y12 inhibition, angiotensin converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB), beta-blocker, and statin. Conclusion The EORP NSTEMI Registry is an international, prospective registry of care and outcomes of patients treated for NSTEMI, which will provide unique insights into the contemporary management of hospitalised NSTEMI patients, compliance with ESC 2015 NSTEMI Guidelines, and identify potential barriers to optimal management of this common clinical presentation associated with significant morbidity and mortality